Trial Profile
A real world observational study evaluating efficacy and safety of Dapagliflozin in patients with type 2 diabetes.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Sep 2017
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 20 Sep 2017 New trial record